4/2gACV5zCAB-b6WZvUKQWEzYv55s-x2khi5uwjOJJGDj_S470O_GU4ss
Matoke® Pharma’s lead pharmaceutical candidate, RO®101, aims to be the ideal wound healing agent, with antimicrobial and biofilm penetration properties. It delivers Reactive Oxygen® for the treatment of Chronic Non-Healing Wounds, including those involving biofilm production as well as multi-drug resistant (MDR) pathogens. This builds on the evidence from our first CE-marked medical device.
Elsewhere, there are currently no existing therapies available or in the pipeline which can penetrate biolfims, stimulate tissue regeneration and provide non-systemic, potent and broad-spectrum antimicrobial treatment. Reactive Oxygen® technology represents a new generation of non-conventional antimicrobial which can also accelerate wound healing and stimulate the immune system. Reactive Oxygen® technology is a major advance in infection management.
Antimicrobial resistance (AMR) is a major global challenge which is expected to kill ten million people every year by 2050, without global action. Reactive Oxygen® is part of the solution.
Registered office address: 2 Michaels Court, Hanney Road, Southmoor, Abingdon, OX13 5HR. Matoke Holdings Company number: 07146235
Matoke Pharma supports the UK Government's recent 5-year AMR Strategy. Read our wider thoughts here: #AMR #StopSuperbugs
Matoke® Pharma welcomes UK Government’s 5-Year AMR Strategy - Matoke Holdings
Matoke® Pharma welcomes the UK’s recent 5-year action plan to tackle antimicrobial resistance (AMR).
matokeholdings.com
Matoke Pharma welcomes the Government's 5-year #AMR Strategy. The battle to #StopSuperbugs requires measurable targets and a global, joined-up approach.
Superbugs don’t respect borders, and the UK’s new #AMR strategy will be vital to keeping people healthy all over the world.
Today @BillGates endorsed our vision for a world where #AntimicrobialResistance is controlled across the globe 🌍💊 #wef19
Globally, excellent research and work is ongoing to tackle #antimicrobial resistance. But will governments show the leadership our populations require? This article on the role vaccinations can play in #AMR is a great example of future opportunity:
Vaccinating Against Superbugs | by Seth Berkley & Jeremy Farrar
The ability to control infectious disease is the bedrock of modern medicine, and vaccines are important tools for keeping such diseases at bay. But va...
www.project-syndicate.org
Matoke Holdings Limited, Matoke Holdings Limited logo, Reactive Oxygen, Reactive Oxygen with atom logo, RO and RO with atom logo are all trademarks of Matoke Holdings Limited.
Registered office address: 2 Michaels Court, Hanney Road, Southmoor, Abingdon, OX13 5HR. Matoke Holdings Company number: 07146235
Matoke Pharma supports the UK Government's recent 5-year AMR Strategy. Read our wider thoughts here: #AMR #StopSuperbugs
Matoke® Pharma welcomes UK Government’s 5-Year AMR Strategy - Matoke Holdings
Matoke® Pharma welcomes the UK’s recent 5-year action plan to tackle antimicrobial resistance (AMR).
matokeholdings.com
Matoke Pharma welcomes the Government's 5-year #AMR Strategy. The battle to #StopSuperbugs requires measurable targets and a global, joined-up approach.
Superbugs don’t respect borders, and the UK’s new #AMR strategy will be vital to keeping people healthy all over the world.
Today @BillGates endorsed our vision for a world where #AntimicrobialResistance is controlled across the globe 🌍💊 #wef19
Globally, excellent research and work is ongoing to tackle #antimicrobial resistance. But will governments show the leadership our populations require? This article on the role vaccinations can play in #AMR is a great example of future opportunity:
Vaccinating Against Superbugs | by Seth Berkley & Jeremy Farrar
The ability to control infectious disease is the bedrock of modern medicine, and vaccines are important tools for keeping such diseases at bay. But va...
www.project-syndicate.org
Matoke Holdings Limited, Matoke Holdings Limited logo, Reactive Oxygen, Reactive Oxygen with atom logo, RO and RO with atom logo are all trademarks of Matoke Holdings Limited.